Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2023-06-30 Remuneration Information
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Offer to buy back shares
Remuneration Information Classification · 99% confidence The document explicitly details an 'Offer to buy back shares' conducted via a 'reverse book-building process' for the purpose of an 'Long Term Incentive Plan (LTIP)'. This action, where a company repurchases its own stock from shareholders, directly corresponds to the definition of 'Transaction in Own Shares'. The document is a specific announcement about this corporate action, not a general regulatory filing (RNS) or a report itself. Therefore, the appropriate code is POS.
2023-06-30 English
Finansiell kalender
Report Publication Announcement Classification · 97% confidence The document is titled "Finansiell kalender" (Financial Calendar) and lists future reporting dates for Vistin Pharma ASA, specifically mentioning the Half-Year Report (Halvårsrapport) on 23.08.2023 and the Q3 Quarterly Report (Kvartalsrapport - Q3) on 25.10.2023. This is not the report itself, but an announcement detailing the schedule for future financial reports. Since there is no specific category for a 'Financial Calendar', and it is an announcement about future regulatory/financial reporting events, it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous regulatory announcement, or potentially a 'Report Publication Announcement' (RPA) if interpreted as announcing the *publication schedule*. Given the content is purely a schedule, RNS is the most appropriate fallback for non-specific regulatory/investor information.
2023-06-22 Norwegian
Financial calendar
Report Publication Announcement Classification · 98% confidence The document text is extremely short (305 characters) and explicitly lists a 'Financial calendar' for Vistin Pharma ASA, detailing dates for the 'Half-yearly Report' and 'Quarterly Report - Q3'. It does not contain the content of these reports but rather announces *when* they will be released. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement about the publication timing of reports suggests a Report Publication Announcement (RPA). Since this is a calendar of future reports rather than an announcement of an already published report, it functions as an announcement regarding the release schedule, making RPA the most appropriate fit among the options, although RNS could also be considered if RPA was too specific. Given the context of announcing report publication dates, RPA is selected.
2023-06-22 English
Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day
Investor Presentation Classification · 98% confidence The document is titled "Capital Markets Day" and contains an agenda, detailed slides on strategy, management team, manufacturing capacity expansion, market analysis for Metformin, and future growth plans (including API CDMO expansion). This format, focusing on strategic updates, operational performance, and future outlook presented to investors, strongly aligns with an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), nor is it a transcript of a call (CT).
2023-06-14 English
Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day
Investor Presentation Classification · 95% confidence The document text explicitly states it is a 'Presentation from today's Capital Markets Day' and mentions that the 'presentation' is attached. A Capital Markets Day presentation is a detailed presentation for investors focusing on strategy and operations, which aligns best with the Investor Presentation (IP) category. Given the very short length (304 chars) and the nature of announcing an attached presentation, it could potentially be an RPA, but the content is clearly an Investor Presentation, making IP the most specific fit for the material being presented, even if this specific filing is the announcement wrapper.
2023-06-14 English
Vistin Pharma ASA: Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a specific transaction (Purchase of shares) by a person in a managerial role (Chief Commercial Officer, Magnus Tolleshaug) involving the issuer's stock (Vistin Pharma ASA). This perfectly matches the definition of Director's Dealing (insider trades) which corresponds to the code DIRS.
2023-05-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.